• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biotechnol Appl Biochem . The SARS-CoV-2 NSP-2, NSP-12 and Spike partial sequence conservation in stool samples from Abadan, Iran

tetano

Editor, Senior Moderator
Biotechnol Appl Biochem


. 2022 Apr 9.
doi: 10.1002/bab.2343. Online ahead of print.
The SARS-CoV-2 NSP-2, NSP-12 and Spike partial sequence conservation in stool samples from Abadan, Iran


Milad Zandi[SUP] 1 [/SUP], Saber Soltani[SUP] 1 [/SUP], Alireza Tabibzadeh[SUP] 2 [/SUP], Sepideh Nasimzadeh[SUP] 3 [/SUP], Emad Behboudi[SUP] 4 [/SUP], Armin Zakeri[SUP] 5 [/SUP], Yousef Erfani[SUP] 6 [/SUP], Shokrollah Salmanzadeh[SUP] 7 [/SUP], Samaneh Abbasi[SUP] 8 [/SUP]



Affiliations

Abstract

Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, the clinical manifestations of the virus have undergone many changes. Recently, there are many reports on gastrointestinal symptoms in COVID-19 patients. This study aimed to perform a detailed phylogenetic study and assessment of different SNVs on the RNA genome of virus isolated from fecal samples of patients with COVID-19 who have gastrointestinal symptoms, which can help to better understand the viral pathogenesis. In the present study, 20 fecal samples were collected by written consent from COVID-19 patients. According to the manufacturer's protocol, virus nucleic acid was extracted from stool samples and confirmed the SARS-CoV-2 genome presence in stool samples by RT-PCR assay. Three viral genes S, nsp12, and nsp2 were amplified using the RT-PCR method and specific primers. The multiple sequencing alignment (MSA) was performed in the CLC word bench and phylogenetic tree generated by the MEGA X based on the neighbor-joining method. Of all cases, 11(55%) were male. The mean age of patients was 33.6 years. Diabetes (70%) and blood pressure (55%) had the most prevalent comorbidities. All of 20 patients were positive for SARS-CoV-2 infection in respiratory samples. Molecular analysis investigation among 20 stool samples revealed that the SARS-CoV-2 genome was found among 10 stool samples and only 3 samples were used for sequencing. The polymorphism and phylogenetic analysis in the SARS-CoV-2 showed a great similarity between all of the evaluated genes with the Wuhan reference sequence and all of the current variants of concern (VOC). The current study represents a great similarity in polymorphism and phylogenetic analysis of the SARS-CoV-2 isolates with the Wuhan reference sequence and all of the current variants of concern (VOC) in the particular evaluated partial sequences of S, nsp12 and nsp2. This article is protected by copyright. All rights reserved.

Keywords: COVID 19; Islamic Republic of Iran; Phylogenetic Relationship; SARS Coronavirus 2; Viral Non-Structural Proteins; spike glycoprotein.
 
Back
Top Bottom